TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33075621

Group type: EXPERIMENTAL
Intervention: DA preload and rice (PDA + R)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rice with sugar solution (PSS + R)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: co-ingestion of rice with vinegar-soaked DA (VDA + R)
Number of subjects: 15

Group type: COMPARATOR
Intervention: rice (reference)
Number of subjects: 15
Study: 36271471

Group type: EXPERIMENTAL
Intervention: TransCon PTH (18 μg/d)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: TransCon PTH
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 33658612

Group type: EXPERIMENTAL
Intervention: Drone landed on abdomen
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Drone hovering over participants in supine position
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Drone landed on abdomen in prone position
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Drone hovering over participants in prone position
Number of subjects: 46
Study: 32487594

Group type: EXPERIMENTAL
Intervention: Health literacy intervention
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention (both health literacy and exercise)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 634
Study: 35353415

Group type: EXPERIMENTAL
Intervention: 9-week school-based mindfulness intervention
Number of subjects: 369

Group type: COMPARATOR
Intervention: Active control group receiving relaxation program
Number of subjects: 369

Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 369
Study: 33794354

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NRT + Contingency Management (CM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switch medications from NRT to varenicline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensify treatment to a higher CM reward schedule
Number of subjects: 0
Study: 32245170

Group type: EXPERIMENTAL
Intervention: Neonatal 25-hydroxyvitamin D3 (25(OH)D3) concentrations, specifically in the fifth quintile
Number of subjects: 1423

Group type: COMPARATOR
Intervention: First quintile of neonatal 25-hydroxyvitamin D3 (25(OH)D3) concentrations
Number of subjects: 1423
Study: 35780589

Group type: EXPERIMENTAL
Intervention: QLC (Qilong capsule) combined with conventional treatment (CT)
Number of subjects: 2302

Group type: COMPARATOR
Intervention: CT alone (non-QLC group)
Number of subjects: 2302
Study: 33667304

Group type: EXPERIMENTAL
Intervention: 80% inspired oxygen
Number of subjects: 2801

Group type: COMPARATOR
Intervention: 30% inspired oxygen
Number of subjects: 2801
Study: 33418612

Group type: EXPERIMENTAL
Intervention: Dynamic hip screw with anti-rotation screw
Number of subjects: 364

Group type: COMPARATOR
Intervention: Dynamic hip screw
Number of subjects: 364
Study: 34728131

Group type: EXPERIMENTAL
Intervention: Neoadjuvant and concurrent androgen deprivation therapy (ADT) for 6 months starting 4 months before prostate radiotherapy
Number of subjects: 393

Group type: COMPARATOR
Intervention: Concurrent and adjuvant ADT for 6 months starting simultaneously with prostate radiotherapy
Number of subjects: 393
Study: 34130902

Group type: EXPERIMENTAL
Intervention: Subjective morning chronotype
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objective-measured morning chronotype
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness
Number of subjects: 0
Study: 35152129

Group type: EXPERIMENTAL
Intervention: Early NIHSS assessment
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of NIHSS increase with ICH volume
Number of subjects: 372
Study: 32796442

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone implant injection
Number of subjects: 42
Study: 35807864

Group type: EXPERIMENTAL
Intervention: Cholecalciferol treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Calcitriol treatment (in vitro)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ethanol vehicle control (in vitro)
Number of subjects: 10
Study: 33188400

Group type: EXPERIMENTAL
Intervention: INTε4+
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: INT (all groups)
Number of subjects: 188
Study: 33049455

Group type: EXPERIMENTAL
Intervention: Appearance Teasing & Bullying animation
Number of subjects: 1329

Group type: EXPERIMENTAL
Intervention: Media & Celebrities animation
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Non-appearance-related animation
Number of subjects: 1329

Group type: EXPERIMENTAL
Intervention: All animations (for girls and boys aged 7-10)
Number of subjects: 1329
Study: 36314323

Group type: EXPERIMENTAL
Intervention: CIRRHOS product (2 gr L-carnitine and 150 mg magnesium) for 16 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo for the first 8 weeks and CIRRHOS product for an additional 8 weeks
Number of subjects: 22
Study: 33851684

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for obese individuals
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for average-weight individuals
Number of subjects: 225

Group type: COMPARATOR
Intervention: No Resistance Training for obese individuals
Number of subjects: 225
Study: 37604396

Group type: EXPERIMENTAL
Intervention: Lozenge containing 2% arginine and probiotics (Lacticaseibacillus rhamnosus, LGG® and Lactobacillus paracasei subsp. paracasei)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 288
Study: 33549047

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) capsules, administered once a week for 4 consecutive weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo capsules, administered once a week for 4 consecutive weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) capsules
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 55
Study: 32140867

Group type: EXPERIMENTAL
Intervention: Morning administration of IFN‐β1a 44 µg (Rebif)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Evening administration of IFN‐β1a 44 µg (Rebif)
Number of subjects: 200
Study: 35822289

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) during hypercapnia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Not taking oral contraceptives (NOC) during hypercapnia
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hypercapnia in all women
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low frequency (LF) Phase in NOC-HH
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low frequency (LF) Phase in OC-LH
Number of subjects: 26
Study: 32565041

Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) approach with Safety Planning Intervention (SPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline (retrospective)
Number of subjects: 0
Study: 36376830

Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: REFIX technology, regenerador + sensitive (RDC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arginine‐containing toothpaste, Colgate Total Daily Repair (PC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: NR-5 technology, Regenerate Enamel Science (RES)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: NOVAMIN technology, Sensodyne Repair and Protect (SRP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoride‐free toothpaste, Colgate Oral Care (NC)
Number of subjects: 60
Study: 34087413

Group type: EXPERIMENTAL
Intervention: Oblique NFLJI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perpendicular NFLJI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Needle injections
Number of subjects: 0
Study: 33239944

Group type: EXPERIMENTAL
Intervention: Inertial Group (IG) - accentuated eccentric training using a rotary inertial device
Number of subjects: 54

Group type: COMPARATOR
Intervention: Plyometric Group (PG) - plyometric exercises
Number of subjects: 54
Study: 35606570

Group type: EXPERIMENTAL
Intervention: Incredible Years (TIY) parenting education
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (EHS without TIY)
Number of subjects: 164
Study: 32232363

Group type: EXPERIMENTAL
Intervention: Glucagon (2 pmol/kg/min intravenous infusion)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle infusion (rate-matched)
Number of subjects: 18
Study: 32367175

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise training program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 49
Study: 34597539

Group type: EXPERIMENTAL
Intervention: Machine learning model using LASSO regression
Number of subjects: 8501

Group type: EXPERIMENTAL
Intervention: Linear model
Number of subjects: 8501
Study: 33187503

Group type: EXPERIMENTAL
Intervention: Hypnotherapeutic group program (5 weekly sessions of 120-min duration, plus 5 hypnosis audiorecords for individual practice at home, plus an educational booklet for stress coping)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Hypnotherapeutic group program
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (educational booklet only)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study: 36184254

Group type: EXPERIMENTAL
Intervention: Glucose supplementation (intervention group)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fructose supplementation (control group)
Number of subjects: 44
Study: 33227157

Group type: EXPERIMENTAL
Intervention: MIM DASH
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention only (non‐hypertensive education)
Number of subjects: 0

Group type: COMPARATOR
Intervention: True control group
Number of subjects: 0
Study: 35450813

Group type: EXPERIMENTAL
Intervention: PCAT attenuation of the right coronary artery (RCA)
Number of subjects: 1697

Group type: EXPERIMENTAL
Intervention: LAP burden >4%
Number of subjects: 1697

Group type: EXPERIMENTAL
Intervention: Combination of PCAT-RCA of ≥−70.5 HU and LAP burden >4%
Number of subjects: 1697

Group type: EXPERIMENTAL
Intervention: LAP burden
Number of subjects: 1697

Group type: EXPERIMENTAL
Intervention: PCAT attenuation
Number of subjects: 1697

Group type: EXPERIMENTAL
Intervention: Combination of LAP burden and PCAT attenuation
Number of subjects: 1697
Study: 33760643

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 36037272

Group type: EXPERIMENTAL
Intervention: CAD/CAM orthoses and night splint
Number of subjects: 34

Group type: COMPARATOR
Intervention: Night splint only
Number of subjects: 34
Study: 33586596

Group type: EXPERIMENTAL
Intervention: 15-method
Number of subjects: 10
Study: 34365136

Group type: EXPERIMENTAL
Intervention: Grade 3 ischemia (G3I)
Number of subjects: 7211

Group type: COMPARATOR
Intervention: Grade 2 ischemia (G2I)
Number of subjects: 7211
Study: 37294244

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study: 34426025

Group type: EXPERIMENTAL
Intervention: Cluster randomized ring vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster randomized mass vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational case-control study design
Number of subjects: 0
Study: 32942203

Group type: EXPERIMENTAL
Intervention: Mind-OP intervention (n = 227)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control condition (n = 229)
Number of subjects: 456
Study: 35627704

Group type: EXPERIMENTAL
Intervention: Kitchen diet (n = 32; 1.2 g fiber in 100 mL)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nutrison Energy® (n = 14; 0.02 g fiber in 100 mL)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nutrison Diason Energy HP® (n = 13; 1.8 g fiber in 100 mL)
Number of subjects: 59
Study: 34950068

Group type: EXPERIMENTAL
Intervention: Compassion Cultivation Training (CCT)
Number of subjects: 161
Study: 33778907

Group type: EXPERIMENTAL
Intervention: Intraoperative blood cell salvage and autotransfusion (IBSA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Non-IBSA
Number of subjects: 110
Study: 33002888

Group type: EXPERIMENTAL
Intervention: GLB + LGx
Number of subjects: 140

Group type: COMPARATOR
Intervention: GLB
Number of subjects: 140
Study: 34903039

Group type: EXPERIMENTAL
Intervention: Semaglutide/liraglutide
Number of subjects: 12637

Group type: EXPERIMENTAL
Intervention: Semaglutide 1.0 mg
Number of subjects: 12637

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 12637
Study: 32768938

Group type: EXPERIMENTAL
Intervention: Yidu-toxicity blocking lung decoction (ICW group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pure western medicine therapy (PWM group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 33253756

Group type: EXPERIMENTAL
Intervention: Routine Fundus Photography (RFP)
Number of subjects: 1447

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1447
Study: 35263343

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS)
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Corn-soy blend (CSB)
Number of subjects: 1609
Study: 33003086

Group type: EXPERIMENTAL
Intervention: DA+ (islet amyloid positive)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DA- (islet amyloid negative)
Number of subjects: 120

Group type: COMPARATOR
Intervention: ND (nondiabetic controls)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DA+
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DA-
Number of subjects: 120

Group type: COMPARATOR
Intervention: ND
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Interlobar arteriosclerosis
Number of subjects: 120
Study: 36209381

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment followed by topical application of triamcinolone acetonide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dermapen treatment followed by topical application of triamcinolone acetonide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Microneedling
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study: 33956794

Group type: EXPERIMENTAL
Intervention: Environmental concern
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Functional and emotional values
Number of subjects: 400
Study: 35188180

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 2 weeks (IXEQ2W)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 4 weeks (IXEQ4W)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 567
Study: 34281470

Group type: EXPERIMENTAL
Intervention: ramucirumab + erlotinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 32927753

Group type: EXPERIMENTAL
Intervention: Highly cooked potato (HP) + rice (HP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Minimally cooked potato (MP) + rice (MP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preload of HP prior to rice meal (PHP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preload of MP prior to rice meal (PMP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (HG) + HP + rice (HG + HP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preload of HG prior to co-ingestion of HP and rice (PHG + HP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Co-preload of HG and HP prior to rice (PHG + PHP + R)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preload of HP prior to co-ingestion of HG and rice (PHP + HG + R)
Number of subjects: 17
Study: 33719795

Group type: EXPERIMENTAL
Intervention: Digital Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 46
Study: 33481328

Group type: EXPERIMENTAL
Intervention: sorafenib + vitamin K2 (menatetrenone, 45 mg daily, orally)
Number of subjects: 44

Group type: COMPARATOR
Intervention: sorafenib only
Number of subjects: 44
Study: 34296646

Group type: EXPERIMENTAL
Intervention: Perceived harsh ecological condition
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Perceived safe ecological condition
Number of subjects: 1098
Study: 35904046

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (ESK) plus standard of care (SoC)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo nasal spray (PBO) plus standard of care (SoC)
Number of subjects: 362
Study: 33844425

Group type: EXPERIMENTAL
Intervention: Immediate intervention group (theory-based health information technology intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control group (routine care for the first 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control group (after crossover to intervention)
Number of subjects: 60
Study: 34574433

Group type: EXPERIMENTAL
Intervention: Physical activity and psychological modification-based intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33009265

Group type: EXPERIMENTAL
Intervention: Bupivacaine pudendal block
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 90
Study: 33153484

Group type: EXPERIMENTAL
Intervention: interprof ACT intervention package for 12 months
Number of subjects: 680

Group type: COMPARATOR
Intervention: care as usual (control group)
Number of subjects: 680
Study: 32598909

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 600 mg per day from 11 to 14 until 34 weeks’ gestation
Number of subjects: 1194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 1194
Study: 34719731

Group type: EXPERIMENTAL
Intervention: THC 8 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CBD 400 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: THC 8 mg + CBD 4 mg (THC + CBDlow)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: THC 12 mg + CBD 400 mg (THC + CBDhigh)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32497599

Group type: EXPERIMENTAL
Intervention: MT10107 (Coretox®)
Number of subjects: 220

Group type: COMPARATOR
Intervention: onabotulinum toxin A (Botox®)
Number of subjects: 220
Study: 35296214

Group type: EXPERIMENTAL
Intervention: Pivotal Response Treatment (PRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 20
Study: 32438716

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with laser irradiation, applied on days 0, 3, 7, and 14 for 2-4 minutes each session
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (non-irradiated group)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 6
Study: 36046945

Group type: EXPERIMENTAL
Intervention: Hybrid care modality
Number of subjects: 121

Group type: COMPARATOR
Intervention: Face-to-face consultation
Number of subjects: 121
Study: 33973828

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy using 660, 800, and 970 nm wavelengths with 30 kJ of energy for 3 minutes
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard of care for wound management
Number of subjects: 11
Study: 35146847

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric Inventory Questionnaire (NPI‐Q)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: NPI‐Q scores
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: NPI‐Q domains (anxiety, apathy/indifference, aberrant motor behaviours, appetite/eating disturbance)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Years of education
Number of subjects: 161

Group type: COMPARATOR
Intervention: Living together
Number of subjects: 161
Study: 34193163

Group type: EXPERIMENTAL
Intervention: Recommended diets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Government supplements due to SARS-CoV-2 pandemic
Number of subjects: 0
Study: 33210772

Group type: EXPERIMENTAL
Intervention: Risk indicator - Smoking
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Moderate/severe periodontitis
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - <16 remaining teeth
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Plaque
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Implant malposition (too vestibular)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Implant brand (Nobel vs. Straumann)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Restoration type (bridge vs. single crown)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Risk indicator - Trauma as reason of tooth loss (vs. caries)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Protective indicator - Interproximal flossing/brushing
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Protective indicator - Proton pump inhibitors
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Protective indicator - Anticoagulants
Number of subjects: 99
Study: 35570493

Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium breve MCC1274 (2×10^10 CFU)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 34636710

Group type: EXPERIMENTAL
Intervention: System-based intervention (individualized health education, diabetes prevention booklet, postpartum booster educational program including dietary and exercise counseling)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Standard treatment (group therapy on diet and physical activity modification)
Number of subjects: 298
Study: 33994160

Group type: EXPERIMENTAL
Intervention: Various interventions including mother-baby psychotherapy, educational or guidance programs, care for premature infants, infant massage, and home visits.
Number of subjects: 41
Study: 32551827

Group type: EXPERIMENTAL
Intervention: Hatha yoga classes (25 minutes, twice weekly for 12 weeks)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 174
Study: 35585696

Group type: EXPERIMENTAL
Intervention: Baloxavir marboxil (oral)
Number of subjects: 1781

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1781